Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMMOL”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Ended earlyNCT02147873
What this trial is testing

Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)
TetraLogic Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT00796562
What this trial is testing

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Who this might be right for
MDSLeukemiasLymphomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107
Not applicableStudy completedNCT01192945
What this trial is testing

Non-interventional Study With Azacitidin (Vidaza®)

Who this might be right for
MDSAMLCMMOL
iOMEDICO AG 150
Early research (Phase 1)Study completedNCT00101179
What this trial is testing

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more
National Cancer Institute (NCI) 63